We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.
– FREEDOM-DM1 data from 5 and 10 mg/kg cohorts in patients with DM1 expected in the first quarter of 2025 – – Study designs of CONNECT program optimized based on encouraging results from early...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.66 | -37.2027972028 | 7.15 | 7.15 | 4.36 | 357330 | 4.67727013 | CS |
4 | -4.47 | -49.8883928571 | 8.96 | 9.15 | 4.36 | 117169 | 5.38942964 | CS |
12 | -5.48 | -54.9648946841 | 9.97 | 10.14 | 4.36 | 105608 | 7.66501063 | CS |
26 | -9.21 | -67.2262773723 | 13.7 | 19.298 | 4.36 | 123082 | 10.85877482 | CS |
52 | 0.42 | 10.3194103194 | 4.07 | 19.298 | 3.81 | 112058 | 11.10407958 | CS |
156 | -11.11 | -71.2179487179 | 15.6 | 20 | 3.72 | 106811 | 11.11031369 | CS |
260 | -11.11 | -71.2179487179 | 15.6 | 20 | 3.72 | 106811 | 11.11031369 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions